• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    UnitedHealth Group Reports First Quarter 2025 Results and Revises Full Year Guidance

    4/17/25 5:55:00 AM ET
    $UNH
    Medical Specialities
    Health Care
    Get the next $UNH alert in real time by email
    • Revised 2025 Earnings Outlook to $24.65 to $25.15 Per Share, Adjusted Earnings $26 to $26.50 Per Share
    • First Quarter Earnings were $6.85 Per Share, Adjusted Earnings $7.20 Per Share
    • Revenues of $109.6 Billion Grew $9.8 Billion Year-Over-Year
    • Consumers Served by UnitedHealthcare Increased by 780,000 Year to Date
    • Optum Health Continues to Expect to Serve 650,000 New Value-Based Care Patients in 2025

    UnitedHealth Group (NYSE:UNH) reported first quarter 2025 results and revised its outlook for the year.

    "UnitedHealth Group grew to serve more people more comprehensively but did not perform up to our expectations, and we are aggressively addressing those challenges to position us well for the years ahead, and return to our long-term earnings growth rate target of 13 to 16%," said Andrew Witty, chief executive officer of UnitedHealth Group.

    UnitedHealth Group revised its 2025 performance outlook established in December 2024 to net earnings of $24.65 to $25.15 per share and adjusted earnings of $26 to $26.50 per share. This outlook reflects two factors:

    • Heightened care activity indications within UnitedHealthcare's Medicare Advantage businesses, which became visible as the quarter closed, far above the planned 2025 increase which was consistent with the elevated levels in 2024. This activity was most notable within physician and outpatient services.
    • Unanticipated changes in the profile of Optum Health members impacting planned 2025 reimbursement due to unexpectedly minimal 2024 beneficiary engagement by plans exiting markets. In addition, a greater-than-expected impact to current and new complex patients from the ongoing Medicare funding reductions enacted by the previous administration.

    The company believes these factors to be highly addressable over the course of this year as well as it looks ahead to 2026.

    Quarterly Financial Performance

     

    Three Months Ended

     

     

    March 31,

    2025

    March 31,

    2024

    December 31,

    2024

     

     

    Revenues

    $109.6 billion

    $99.8 billion

    $100.8 billion

    Earnings from Operations

    $ 9.1 billion

    $ 7.9 billion

    $ 7.8 billion

    Net Margin

    5.7%

    (1.4)%

    5.5%

    • UnitedHealth Group's first quarter 2025 revenues grew $9.8 billion year-over-year to $109.6 billion, driven primarily by serving people more comprehensively across the enterprise. First quarter earnings from operations were $9.1 billion.
    • The first quarter medical care ratio was 84.8% compared to 84.3% in 2024. The increase was primarily due to the revenue effects of both the ongoing Medicare funding reductions and member mix and the higher senior care activity, partially offset by the Medicare Part D program changes which affected seasonality. The company did not reflect any favorable earnings impacting medical reserve development in the quarter.
    • Days claims payable of 45.5 compared to 47.0 in the fourth quarter 2024 and 47.1 in first quarter 2024. This was driven by the Medicare Part D program changes noted previously.
    • The first quarter 2025 operating cost ratio of 12.4% compared to 14.1% in 2024, reflecting revenue impacts from the Part D program and increased technological and other operating efficiencies across UnitedHealthcare and Optum.
    • Cash flows from operations for the first quarter were $5.5 billion. During the first quarter 2025, the company returned nearly $5 billion to shareholders through dividends and share repurchases. Return on equity of 26.8% in the first quarter, reflected the company's consistent, broad-based earnings and efficient capital structure.

    UnitedHealthcare provides health care benefits globally, serving individuals and employers, and Medicare and Medicaid beneficiaries. UnitedHealthcare is dedicated to improving the value customers and consumers receive by improving health and wellness, enhancing the quality of care received, simplifying the health care experience and reducing the total cost of care.

    Quarterly Financial Performance

     

    Three Months Ended

     

    March 31,

    2025

    March 31,

    2024

    December 31,

    2024

     

     

    Revenues

    $84.6 billion

    $75.4 billion

    $74.1 billion

    Earnings from Operations

    $ 5.2 billion

    $ 4.4 billion

    $ 3.0 billion

    Operating Margin

    6.2%

    5.8%

    4.0%

    • UnitedHealthcare first quarter revenues of $84.6 billion grew by $9.3 billion year-over-year. Operating earnings were $5.2 billion, impacted by higher-than-expected care activity levels within UnitedHealthcare's Medicare Advantage business.
    • The number of consumers served with self-funded commercial benefits increased by about 700,000 in the first quarter, reflecting strong customer response to the company's innovative offerings. Commercial insured membership was impacted by attrition within individual exchange offerings due to a highly price-competitive marketplace.
    • The number of people served by the company's offerings for seniors and people with complex needs grew by 545,000 in the first quarter and remains expected to grow up to 800,000 in 2025.
    • People served by the company's state-based community plans increased to 7.6 million members, and the company expanded customer relationships in Kentucky, New York and Florida.

    The Optum health services businesses serve the global health care marketplace, including payers, care providers, employers, governments, life sciences companies and consumers. Using market-leading information, analytics and technology to yield clinical insights, Optum helps improve overall health system performance by optimizing care quality, reducing care costs and improving the consumer experience.

    Quarterly Financial Performance

     

    Three Months Ended

     

    March 31,

    2025

    March 31,

    2024

    December 31,

    2024

     

     

    Revenues

    $63.9 billion

    $61.1 billion

    $65.1 billion

     

    Earnings from Operations

    $ 3.9 billion

    $ 3.5 billion

    $ 4.8 billion

     

    Operating Margin

    6.1%

    5.8%

    7.4%

     

    • Optum first quarter revenues of $63.9 billion increased $2.8 billion led by Optum Rx. Operating earnings were $3.9 billion.
    • Optum Health revenues were $25.3 billion. The year-over-year change reflected growth in patients served, offset by legacy customer contract revisions and the member profile factors noted above. Optum Health continues to expect to grow to serve 650,000 new value-based care patients in 2025.
    • Optum Insight revenues were $4.6 billion and the revenue backlog was $32.9 billion. New products coming to market in the first quarter included the launch of AI powered claims processing tools that can increase productivity by over 20% for our revenue cycle management customers.
    • Optum Rx revenues were $35.1 billion, with the strong growth driven by new clients served as well as expanded relationships with existing clients. Adjusted scripts grew to 408 million, compared to 395 million last year.

    About UnitedHealth Group

    UnitedHealth Group (NYSE:UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of health benefits, enabling affordable coverage, simplifying the health care experience and delivering access to high-quality care. Visit UnitedHealth Group at www.unitedhealthgroup.com and follow UnitedHealth Group on LinkedIn.

    Earnings Conference Call

    As previously announced, UnitedHealth Group will discuss the company's results, strategy and future outlook on a conference call with investors at 8:45 a.m. Eastern Time today. UnitedHealth Group will host a live webcast of this conference call from the Investor Relations page of the company's website (www.unitedhealthgroup.com). Following the call, a webcast replay will be on the Investor Relations page through May 1, 2025. This earnings release and the Form 8-K dated April 17, 2025, can also be accessed from the Investor Relations page of the company's website.

    Non-GAAP Financial Information

    This news release presents non-GAAP financial information provided as a complement to the results provided in accordance with accounting principles generally accepted in the United States of America ("GAAP"). A reconciliation of the non-GAAP financial information to the most directly comparable GAAP financial measure is provided in the accompanying tables found at the end of this release.

    Forward-Looking Statements

    The statements, estimates, projections, guidance or outlook contained in this document include "forward-looking" statements which are intended to take advantage of the "safe harbor" provisions of the federal securities laws. The words "believe," "expect," "intend," "estimate," "anticipate," "forecast," "outlook," "plan," "project," "should" and similar expressions identify forward-looking statements. These statements may contain information about financial prospects, economic conditions and trends and involve risks and uncertainties. Actual results could differ materially from those that management expects, depending on the outcome of certain factors including: our ability to effectively estimate, price for and manage medical costs; new or changes in existing health care laws or regulations, or their enforcement or application; cyberattacks, other privacy/data security incidents, or our failure to comply with related regulations; reductions in revenue or delays to cash flows received under government programs; changes in Medicare, the CMS star ratings program or the application of risk adjustment data validation audits; the DOJ's legal action relating to the risk adjustment submission matter; our ability to maintain and achieve improvement in quality scores impacting revenue; failure to maintain effective and efficient information systems or if our technology products do not operate as intended; risks and uncertainties associated with our businesses providing pharmacy care services; competitive pressures, including our ability to maintain or increase our market share; changes in or challenges to our public sector contract awards; failure to achieve targeted operating cost productivity improvements; failure to develop and maintain satisfactory relationships with health care payers, physicians, hospitals and other service providers; the impact of potential changes in tax laws and regulations; increases in costs and other liabilities associated with litigation, government investigations, audits or reviews; failure to complete, manage or integrate strategic transactions; risk and uncertainties associated with the sale of our remaining operations in South America; risks associated with public health crises arising from large-scale medical emergencies, pandemics, natural disasters and other extreme events; failure to attract, develop, retain, and manage the succession of key employees and executives; our investment portfolio performance; impairment of our goodwill and intangible assets; failure to protect proprietary rights to our databases, software and related products; downgrades in our credit ratings; and our ability to obtain sufficient funds from our regulated subsidiaries or from external financings to fund our obligations, reinvest in our business, maintain our debt to total capital ratio at targeted levels, maintain our quarterly dividend payment cycle, or continue repurchasing shares of our common stock.

    This above list is not exhaustive. We discuss these matters, and certain risks that may affect our business operations, financial condition and results of operations, more fully in our filings with the SEC, including our reports on Forms 10-K, 10-Q and 8-K. By their nature, forward-looking statements are not guarantees of future performance or results and are subject to risks, uncertainties and assumptions that are difficult to predict or quantify. Actual results may vary materially from expectations expressed or implied in this document or any of our prior communications. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. We do not undertake to update or revise any forward-looking statements, except as required by law.

    UNITEDHEALTH GROUP

    Earnings Release Schedules and Supplementary Information

    Quarter Ended March 31, 2025

     
    • Condensed Consolidated Statements of Operations
    • Condensed Consolidated Balance Sheets
    • Condensed Consolidated Statements of Cash Flows
    • Supplemental Financial Information - Businesses
    • Supplemental Financial Information - People Served and Performance Metrics
    • Reconciliation of Non-GAAP Financial Measure

    UNITEDHEALTH GROUP

    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

    (in millions, except per share data; unaudited)

     

     

     

    Three Months Ended

    March 31,

     

     

    2025

     

    2024

    Revenues

     

     

     

     

    Premiums

     

    $86,534

     

    $77,988

    Products

     

    13,036

     

    11,909

    Services

     

    8,972

     

    8,888

    Investment and other income

     

    1,033

     

    1,011

    Total revenues

     

    109,575

     

    99,796

    Operating costs

     

     

     

     

    Medical costs

     

    73,411

     

    65,735

    Operating costs

     

    13,594

     

    14,077

    Cost of products sold

     

    12,390

     

    11,056

    Depreciation and amortization

     

    1,061

     

    997

    Total operating costs

     

    100,456

     

    91,865

    Earnings from operations

     

    9,119

     

    7,931

    Interest expense

     

    (998)

     

    (844)

    Loss on sale of subsidiary and subsidiaries held for sale

     

    (15)

     

    (7,086)

    Earnings before income taxes

     

    8,106

     

    1

    Provision for income taxes

     

    (1,632)

     

    (1,222)

    Net earnings (loss)

     

    6,474

     

    (1,221)

    Earnings attributable to noncontrolling interests

     

    (182)

     

    (188)

    Net earnings (loss) attributable to UnitedHealth Group common shareholders

     

    $6,292

     

    $(1,409)

    Diluted earnings (loss) per share attributable to UnitedHealth Group common shareholders

     

    $6.85

     

    $(1.53)

    Adjusted earnings per share attributable to UnitedHealth Group common shareholders (a)

     

    $7.20

     

    $6.91

    Diluted weighted-average common shares outstanding

     

    918

     

    922

     
    (a) See page 6 for a reconciliation of non-GAAP measures.  

    UNITEDHEALTH GROUP

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (in millions; unaudited)

     

     

     

    March 31,

    2025

     

    December 31,

    2024

    Assets

     

     

     

     

    Cash and short-term investments

     

    $34,291

     

    $29,113

    Accounts receivable, net

     

    26,936

     

    22,365

    Other current assets

     

    35,058

     

    34,301

    Total current assets

     

    96,285

     

    85,779

    Long-term investments

     

    51,863

     

    52,354

    Other long-term assets

     

    161,642

     

    160,145

    Total assets

     

    $309,790

     

    $298,278

    Liabilities, redeemable noncontrolling interests and equity

     

     

     

     

    Medical costs payable

     

    $37,136

     

    $34,224

    Short-term borrowings and current maturities of long-term debt

     

    9,986

     

    4,545

    Other current liabilities

     

    66,349

     

    65,000

    Total current liabilities

     

    113,471

     

    103,769

    Long-term debt, less current maturities

     

    71,285

     

    72,359

    Other long-term liabilities

     

    19,865

     

    19,559

    Redeemable noncontrolling interests

     

    4,358

     

    4,323

    Equity

     

    100,811

     

    98,268

    Total liabilities, redeemable noncontrolling interests and equity

     

    $309,790

     

    $298,278

    UNITEDHEALTH GROUP

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (in millions; unaudited)

     

     

     

    Three Months Ended

    March 31,

     

     

    2025

     

    2024

    Operating Activities

     

     

     

     

    Net earnings (loss)

     

    $6,474

     

    $(1,221)

    Noncash items:

     

     

     

     

    Depreciation and amortization

     

    1,061

     

    997

    Deferred income taxes and other

     

    161

     

    152

    Share-based compensation

     

    375

     

    372

    Loss on sale of subsidiary and subsidiaries held for sale

     

    15

     

    7,086

    Net changes in operating assets and liabilities

     

    (2,630)

     

    (6,242)

    Cash flows from operating activities

     

    5,456

     

    1,144

    Investing Activities

     

     

     

     

    Sales and maturities of investments, net of purchases

     

    1,217

     

    492

    Purchases of property, equipment and capitalized software

     

    (898)

     

    (743)

    Cash paid for acquisitions and other transactions, net

     

    (702)

     

    (3,006)

    Loans to care providers - cyberattack

     

    —

     

    (2,164)

    Repayments of care provider loans - cyberattack

     

    891

     

    —

    Other, net

     

    (582)

     

    (919)

    Cash flows used for investing activities

     

    (74)

     

    (6,340)

    Financing Activities

     

     

     

     

    Common share repurchases

     

    (3,000)

     

    (3,072)

    Dividends paid

     

    (1,912)

     

    (1,729)

    Net change in short-term borrowings and long-term debt

     

    3,911

     

    11,364

    Other, net

     

    1,100

     

    1,668

    Cash flows from financing activities

     

    99

     

    8,231

    Effect of exchange rate changes on cash and cash equivalents

     

    15

     

    (48)

    Increase in cash and cash equivalents, including cash within businesses held for sale

     

    5,496

     

    2,987

    Less: net increase in cash within businesses held for sale

     

    (91)

     

    —

    Net increase in cash and cash equivalents

     

    5,405

     

    2,987

    Cash and cash equivalents, beginning of period

     

    25,312

     

    25,427

    Cash and cash equivalents, end of period

     

    $30,717

     

    $28,414

    UNITEDHEALTH GROUP

    SUPPLEMENTAL FINANCIAL INFORMATION - BUSINESSES

    (in millions, except percentages)

    (unaudited)

     

     

     

    Three Months Ended

    March 31,

     

     

    2025

     

    2024

    Revenues

     

     

     

     

    UnitedHealthcare

     

    $84,617

     

    $75,357

    Optum

     

    63,885

     

    61,052

    Eliminations

     

    (38,927)

     

    (36,613)

    Total consolidated revenues

     

    $109,575

     

    $99,796

    Earnings from Operations

     

     

     

     

    UnitedHealthcare

     

    $5,226

     

    $4,395

    Optum (a)

     

    3,893

     

    3,536

    Total consolidated earnings from operations

     

    $9,119

     

    $7,931

    Operating Margin

     

     

     

     

    UnitedHealthcare

     

    6.2%

     

    5.8%

    Optum

     

    6.1%

     

    5.8%

    Consolidated operating margin

     

    8.3%

     

    7.9%

     

     

     

     

     

    Revenues

     

     

     

     

    UnitedHealthcare Employer & Individual - Domestic

     

    $19,066

     

    $17,839

    UnitedHealthcare Employer & Individual - Global

     

    782

     

    1,532

    UnitedHealthcare Employer & Individual - Total

     

    19,848

     

    19,371

    UnitedHealthcare Medicare & Retirement

     

    41,705

     

    35,486

    UnitedHealthcare Community & State

     

    23,064

     

    20,500

     

     

     

     

     

    Optum Health

     

    $25,309

     

    $26,731

    Optum Insight

     

    4,630

     

    4,502

    Optum Rx

     

    35,132

     

    30,835

    Optum eliminations

     

    (1,186)

     

    (1,016)

    (a)  

    Earnings from operations for Optum for the three months ended March 31, 2025 and 2024 included $1,614 and $1,899 for Optum Health; $961 and $490 for Optum Insight; and $1,318 and $1,147 for Optum Rx, respectively.

    UNITEDHEALTH GROUP

    SUPPLEMENTAL FINANCIAL INFORMATION - PEOPLE SERVED AND PERFORMANCE METRICS

    (unaudited)

    UnitedHealthcare Customer Profile

    (in thousands)

     

    People Served

     

    March 31, 2025

     

    December 31, 2024

     

    March 31, 2024

    Commercial:

     

     

     

     

     

     

    Risk-based

     

    8,410

     

    8,845

     

    8,545

    Fee-based

     

    21,590

     

    20,885

     

    20,870

    Total Commercial

     

    30,000

     

    29,730

     

    29,415

    Medicare Advantage

     

    8,245

     

    7,845

     

    7,760

    Medicaid

     

    7,570

     

    7,435

     

    7,680

    Medicare Supplement (Standardized)

     

    4,310

     

    4,335

     

    4,325

    Total Community and Senior

     

    20,125

     

    19,615

     

    19,765

    Total UnitedHealthcare - Medical

     

    50,125

     

    49,345

     

    49,180

     

     

     

     

     

     

     

    Supplemental Data

     

     

     

     

     

     

    Medicare Part D stand-alone

     

    2,835

     

    3,050

     

    3,085

    South American businesses held for sale

     

    1,160

     

    1,330

     

    2,295

    Optum Performance Metrics

     

     

     

    March 31, 2025

     

    December 31, 2024

     

    March 31, 2024

    Optum Health Consumers Served (in millions)

     

    99

     

    100

     

    104

    Optum Insight Contract Backlog (in billions)

     

    $32.9

     

    $32.8

     

    $32.8

    Optum Rx Quarterly Adjusted Scripts (in millions)

     

    408

     

    422

     

    395

    UNITEDHEALTH GROUP

    RECONCILIATION OF NON-GAAP FINANCIAL MEASURE

    Use of Non-GAAP Financial Measure

    Adjusted net earnings per share is a non-GAAP financial measure. Non-GAAP financial measures should be considered in addition to, but not as a substitute for, or superior to, financial measures prepared in accordance with GAAP. Adjustments to adjusted net earnings per share are as follows:

     

    Intangible Amortization: As amortization fluctuates based on the size and timing of the company's acquisition activity, management believes this exclusion provides a more useful comparison of the company's underlying business performance and trends from period to period. While intangible assets contribute to the Company's revenue generation, the intangible amortization is not directly related. Therefore, the related revenues are included in adjusted earnings per share.

     

    South American Impacts: The loss on the sale of our Brazilian operations completed on February 6, 2024 is not representative of the Company's underlying business performance and therefore management believes the exclusion presents a more useful comparison of the company's underlying business performance and trends from period to period.

     

    Direct Response Costs - Cyberattack: Management believes the exclusion of costs incurred to investigate and remediate the attack, other direct and incremental costs incurred as a result of the cyberattack and incremental costs for accommodations to support care providers presents a more useful comparison of the Company's underlying business performance and trends from period to period.

    UNITEDHEALTH GROUP

    RECONCILIATION OF NON-GAAP FINANCIAL MEASURE

    (in millions, except per share data; unaudited)

    Adjusted Net Earnings Per Share

     

     

     

    Three Months Ended

    March 31,

     

    Projected Year Ended

    December 31,

     

     

    2025

     

    2024

     

    2025

    Net earnings (loss) attributable to UnitedHealth Group common shareholders

     

    $6,292

     

    $(1,409)

     

    $22,500 - $23,100

    Intangible amortization

     

    417

     

    399

     

    ~1,625

    Tax effect of intangible amortization

     

    (102)

     

    (98)

     

    ~(400)

    South American impacts

     

    —

     

    7,086

     

    —

    Direct response costs - cyberattack

     

    —

     

    593

     

    —

    Tax effect of direct response costs - cyberattack

     

    —

     

    (141)

     

    —

    Adjusted net earnings attributable to UnitedHealth Group common shareholders

     

    $6,607

     

    $6,430

     

    $23,725 - $24,325

     

     

     

     

     

     

     

    Diluted earnings (loss) per share

     

    $6.85

     

    $(1.53)

     

    $24.65 - $25.15

    Intangible amortization per share

     

    0.46

     

    0.43

     

    ~1.75

    Tax effect of intangible amortization per share

     

    (0.11)

     

    (0.10)

     

    ~(0.40)

    South American impacts per share

     

    —

     

    7.62

     

    —

    Direct response costs - cyberattack per share

     

    —

     

    0.64

     

    —

    Tax effects of direct response costs - cyberattack per share

     

    —

     

    (0.15)

     

    —

    Adjusted diluted earnings per share

     

    $7.20

     

    $6.91

     

    $26.00 - $26.50

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250417145544/en/

    Investors:

    [email protected]

    Media:

    [email protected]

    Get the next $UNH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $UNH

    DatePrice TargetRatingAnalyst
    4/22/2025$490.00Buy → Hold
    HSBC Securities
    4/21/2025Buy → Hold
    Argus
    1/10/2025$595.00Hold → Buy
    HSBC Securities
    1/6/2025$625.00 → $610.00Buy
    Truist
    10/17/2024Buy → Hold
    HSBC Securities
    10/11/2024$675.00Overweight
    KeyBanc Capital Markets
    7/17/2024$555.00 → $615.00Outperform
    RBC Capital Mkts
    7/17/2024$481.00 → $647.00Hold → Buy
    Jefferies
    More analyst ratings

    $UNH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Flynn Timothy Patrick was granted 180 shares, increasing direct ownership by 2% to 9,123 units (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      4/3/25 4:54:06 PM ET
      $UNH
      Medical Specialities
      Health Care
    • Director Noseworthy John H was granted 180 shares, increasing direct ownership by 3% to 5,763 units (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      4/3/25 4:53:55 PM ET
      $UNH
      Medical Specialities
      Health Care
    • Director Mcnabb Frederick William Iii was granted 183 shares, increasing direct ownership by 1% to 13,656 units (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      4/3/25 4:53:44 PM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • CareXM adds Home-Based Care Industry Leader, Carla Davis, to its Board of Directors

      CareXM, the leading provider of clinical triage and virtual care coordination solutions for post-acute care, announced today that Carla Davis has been appointed as an independent member of its Board of Directors, effective May 6, 2025. Davis joins the Board following an impressive 30-year career in home health and hospice, serving most recently as Senior Vice President of Hospice Operations at LHC Group. "We are excited to welcome Carla to CareXM's Board of Directors," said Si Luo, chief executive officer at CareXM. "Carla was one of the first customer leaders I had the privilege of meeting after joining CareXM, and from our first conversation, her unwavering commitment to advancing the pa

      5/7/25 8:46:00 AM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth Group Reports First Quarter 2025 Results and Revises Full Year Guidance

      Revised 2025 Earnings Outlook to $24.65 to $25.15 Per Share, Adjusted Earnings $26 to $26.50 Per Share First Quarter Earnings were $6.85 Per Share, Adjusted Earnings $7.20 Per Share Revenues of $109.6 Billion Grew $9.8 Billion Year-Over-Year Consumers Served by UnitedHealthcare Increased by 780,000 Year to Date Optum Health Continues to Expect to Serve 650,000 New Value-Based Care Patients in 2025 UnitedHealth Group (NYSE:UNH) reported first quarter 2025 results and revised its outlook for the year. "UnitedHealth Group grew to serve more people more comprehensively but did not perform up to our expectations, and we are aggressively addressing those challenges to position us well

      4/17/25 5:55:00 AM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth Group Announces Earnings Release Date

      UnitedHealth Group (NYSE:UNH) will release its first quarter 2025 financial results on Thursday, April 17, 2025, before the market opens, and will host a teleconference at 8:45 a.m. ET to discuss the results with analysts and investors. This call will be webcast on the Investor Relations page of the company's website (www.unitedhealthgroup.com). The replay will be available through May 1 on the website. About UnitedHealth Group UnitedHealth Group (NYSE:UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technol

      3/24/25 6:50:00 AM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • UnitedHealth downgraded by HSBC Securities with a new price target

      HSBC Securities downgraded UnitedHealth from Buy to Hold and set a new price target of $490.00

      4/22/25 7:23:13 AM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth downgraded by Argus

      Argus downgraded UnitedHealth from Buy to Hold

      4/21/25 8:37:42 AM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth upgraded by HSBC Securities with a new price target

      HSBC Securities upgraded UnitedHealth from Hold to Buy and set a new price target of $595.00

      1/10/25 9:15:00 AM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $UNH
    SEC Filings

    See more

    $UNH
    Leadership Updates

    Live Leadership Updates

    See more
    • Director Flynn Timothy Patrick bought $511,575 worth of shares (1,000 units at $511.57) (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      1/22/25 4:05:59 PM ET
      $UNH
      Medical Specialities
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by UnitedHealth Group Incorporated

      SCHEDULE 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

      5/7/25 10:07:23 AM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth Group Incorporated filed SEC Form 8-K: Leadership Update

      8-K - UNITEDHEALTH GROUP INC (0000731766) (Filer)

      4/29/25 4:02:36 PM ET
      $UNH
      Medical Specialities
      Health Care
    • SEC Form DEFA14A filed by UnitedHealth Group Incorporated

      DEFA14A - UNITEDHEALTH GROUP INC (0000731766) (Filer)

      4/21/25 4:06:26 PM ET
      $UNH
      Medical Specialities
      Health Care
    • Charlie Baker Joins UnitedHealth Group's Board of Directors

      UnitedHealth Group (NYSE:UNH) announced Charlie Baker, the former governor of Massachusetts and a prominent former health care executive, has been appointed to its Board of Directors, effective immediately. "Charlie Baker's leadership and deep health care experience will serve UnitedHealth Group well in its efforts to make the health system work better for everyone," said UnitedHealth Group Board Chairman Stephen J. Hemsley. "Charlie is an outstanding addition to our board given his proven track record in government and in leading businesses in the health sector, including care delivery and benefits." "UnitedHealth Group has unique capabilities to improve health care outcomes, lower cos

      11/3/23 4:00:00 PM ET
      $UNH
      Medical Specialities
      Health Care
    • DNAnexus Announces Appointment of Thomas Laur as CEO

      Proven healthcare executive brings decades of experience leading successful software, data, and services companies Richard Daly remains actively involved as a member of the Board of Directors DNAnexus Inc., the leading provider of cloud-based genomic and biomedical data management and analysis software, today announced that Thomas Laur has been appointed Chief Executive Officer and member of the company's Board of Directors, effective September 11, 2023. Mr. Laur succeeds Richard Daly, who has overseen the company's significant growth since 2013 and will remain an active advisor and a member of the Board of Directors. "It has been the greatest privilege of my life to have led the evol

      9/12/23 9:02:00 AM ET
      $UNH
      Medical Specialities
      Health Care
    • Tactile Medical Appoints Elaine Birkemeyer as Chief Financial Officer

      MINNEAPOLIS, March 14, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (NASDAQ:TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Elaine Birkemeyer to the position of Chief Financial Officer, effective March 20, 2023. Ms. Birkemeyer will succeed Brent Moen, who is retiring. "Elaine is a dynamic and purpose-driven leader with over 25 years of experience in finance, accounting, and business strategy, including extensive senior leadership experience at multiple Fortune 500 companies, leading large divisions within the healthcare, consumer and retail industries," said Da

      3/14/23 9:00:00 AM ET
      $BBY
      $SNBR
      $TCMD
      $TGT
      Consumer Electronics/Video Chains
      Consumer Discretionary
      Home Furnishings
      Medical/Dental Instruments

    $UNH
    Financials

    Live finance-specific insights

    See more
    • UnitedHealth Group Reports First Quarter 2025 Results and Revises Full Year Guidance

      Revised 2025 Earnings Outlook to $24.65 to $25.15 Per Share, Adjusted Earnings $26 to $26.50 Per Share First Quarter Earnings were $6.85 Per Share, Adjusted Earnings $7.20 Per Share Revenues of $109.6 Billion Grew $9.8 Billion Year-Over-Year Consumers Served by UnitedHealthcare Increased by 780,000 Year to Date Optum Health Continues to Expect to Serve 650,000 New Value-Based Care Patients in 2025 UnitedHealth Group (NYSE:UNH) reported first quarter 2025 results and revised its outlook for the year. "UnitedHealth Group grew to serve more people more comprehensively but did not perform up to our expectations, and we are aggressively addressing those challenges to position us well

      4/17/25 5:55:00 AM ET
      $UNH
      Medical Specialities
      Health Care
    • AM Best Affirms Credit Ratings of UnitedHealth Group Incorporated and Its Subsidiaries

      AM Best has affirmed the Long-Term Issuer Credit Ratings (Long-Term ICR) of "a" (Excellent) and the Long- and Short-Term Issuer Credit Ratings (Long-Term IR; Short-Term IR) of UnitedHealth Group Incorporated (UnitedHealth Group) (Minnetonka, MN) (NYSE:UNH). Concurrently, AM Best has affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term ICRs of "aa-" (Superior) of the health and dental insurance subsidiaries of UnitedHealth Group, collectively referred to as UnitedHealthcare. The outlook of these Credit Ratings (ratings) is stable. (See link below for a detailed listing of the companies and ratings.) The ratings reflect UnitedHealthcare's balance sheet strength, wh

      3/12/25 4:20:00 PM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth Group Board Authorizes Payment of Quarterly Dividend

      The UnitedHealth Group (NYSE:UNH) board of directors has authorized payment of a cash dividend of $2.10 per share, to be paid on March 18, 2025, to all shareholders of record of UNH common stock as of the close of business March 10, 2025. About UnitedHealth Group UnitedHealth Group (NYSE:UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of health b

      2/24/25 6:50:00 AM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

      SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

      2/13/24 5:16:09 PM ET
      $UNH
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

      SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

      2/9/24 10:05:20 AM ET
      $UNH
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

      SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

      2/9/23 12:39:51 PM ET
      $UNH
      Medical Specialities
      Health Care